serotonin syndromeThe clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced
Catatonia, neuroleptic malignant syndrome, and serotonin syndrome . In: Stern TA, Herman JB, eds. Massachusetts General Hospital Psychiatry Update & Board Preparation, 2nd ed. New York, NY: McGraw-Hill. 2004. 217–224.Reddick B, Stern TA. Catatonia, neuroleptic malignant syndrome, and ...
An overview of serotonin syndrome (SS) vs neuroleptic malignant syndrome (NMS), including the different signs and symptoms and how to distinguish these conditions.
Epidemiology Neuroleptic malignant syndrome (NMS) is rare, diagnosed annually in 2,000 hospitalized patients in the US Recent studies suggest an incidence of 0.01–0.02% in patients treated with antipsychotic medications Risk factorsdoi:10.1007/978-1-4419-6842-5_27Panayiotis N. Varelas...
Serotonin syndrome vs. NMS Neuroleptic malignant syndrome (NMS)is similar to serotonin syndrome. This condition is rare but very serious. If it's not treated quickly, it can lead to death. But most people recover fully after treatment.
neuroleptic malignant syndrome; PRISMA, Preferred reporting items for systematic reviews and meta-analyses; RC, Radomski criteria; RCT, randomized controlled trial; SC, Sternbach criteria; SGA, second generation antipsychotic; SS, serotonin syndrome; SSRI, selective serotonin reuptake inhibitor Acknowledgement...
A. Wilborn, “Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management,” Annals of Clinical Psychiatry, vol. 24, no. 2, pp. 155–162, 2012. [32] A. Graudins, A. Stearman, B. Chan, and K. Kulig, “Treatment of the serotonin syndrome ...
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep. 2014;23:1-4.Dosi R, Ambaliya A, Joshi H, Patell R. Serotonin syndrome versus neuro- leptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep. 2014. doi:10.1136/...
Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin. Pharm. 8, 510-514.Kline SS, Mauro LS, Scala-Barnett DM, Zick D. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm 1989; 8:510-4....
Neuroleptic malignant syndrome (NMS) develops during the use of neuroleptics, whereas serotonin syndrome is caused mainly by serotoninergic antidepressants. Although both syndromes show various symptoms, hyperthermia is the main clinical manifestation. In this review we describe the historical background, ...